Manual Lymphatic Drainage in Fibromyalgia Syndrome
The Effectiveness of Manual Lymphatic Drainage in Fibromyalgia Syndrome
1 other identifier
interventional
20
1 country
1
Brief Summary
There are limited studies on the use of Manual Lymphatic Drainage (MLD) in fibromyalgia syndrome. Considering the possible mechanisms of action of MLD and the pathophysiology of fibromyalgia, more studies are needed to fully determine the effect of MLD on this syndrome. The aim of this study was to investigate the effectiveness of manual lymphatic drainage on symptom severity, pain intensity, pressure pain threshold and anxiety about pain in fibromyalgia syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 23, 2022
CompletedFirst Posted
Study publicly available on registry
June 29, 2022
CompletedStudy Start
First participant enrolled
July 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 25, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2024
CompletedMarch 6, 2025
March 1, 2025
1.1 years
June 23, 2022
March 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Fibromyalgia Impact Questionnaire (FIQ)
The FIQ is an assessment and evaluation instrument developed to measure fibromyalgia (FM) patient status, progress and outcomes.
5 minutes
Pressure pain thresholds (PPT)
Pressure pain thresholds in following three points, 7th cervical vertebra,6th thoracal vertebra and 3th lumbal vertebra were measured using a analog pressure algometer (Baseline, USA).
10 minutes
Visual Analogue Scale
A 0-100mm Visual Analogue Scale (VAS) will be used to assess pain intensity. The VAS is a scale on a straight line with a value of "0" indicating "no pain intensity" and a value of "100" indicating "severe pain". Participants will be asked to mark the pain they feel on this line.
1 minutes
Secondary Outcomes (1)
Concerns About Pain
5 minutes
Study Arms (2)
Manual Lymphatic Drainage Group
EXPERIMENTALManual Lymphatic Drainage (MLD) in addition to medical treatment is applied to participants in this group.
Sham Group
SHAM COMPARATORSham Manual Lymphatic Drainage (MLD) in addition to medical treatment is applied to participants in this group.
Interventions
Manual Lymphatic Drainage (MLD) is applied towards the flow direction of lymph vessels with special hand movements. MLD is made with very light, completely painless and rhythmic translational movements of the skin. MLD, by expert and trained physiotherapists (G.K, H.K) in this field. It will be applied with the techniques defined by Dr. Vodder. MLD ( to the neck region, abdominal region, axillary and inguinal lymph nodes) will be applied by following the lymphatic pathways specific to the anterior and posterior trunk, respectively. The treatment session will take approximately 45 minutes. It will be applied 5 days a week during 3 weeks.
The patients in control group continued taking their regular gabapentin and pregabalin-derivative drug therapy at the same dosage and duration specified by their physicians.
Sham MLD will be administered by MLD-trained physiotherapists (G.K, H.K) with a protocol that is far from techniques that reveal the physiological effects of MLD. Sham application consists of applications that do not follow the lymphatic pathways from distal to proximal to the trunk, neck, and abdominal region, and superficial breathing. The session will take approximately 45 minutes.
Eligibility Criteria
You may qualify if:
- have fibromyalgia as defined by the criteria of the 2016 ACR
- have Turkish as their native language
- between 18 and 65 years of age
You may not qualify if:
- Having cognitive impairment
- Receiving routine physiotherapy and/or manual therapy, alternative/complementary therapies
- Illiterate people
- Diagnosed with endocrine, neuromuscular, infectious and inflammatory diseases
- Diagnosed severe mental and psychological disorders
- Having malignancy
- Pregnant or people who breastfeed
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kutahya Health Sciences University Evliya Celebi Hospital
Kütahya, 43100, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gamze KURT, Ph.D.
Kutahya Health Sciences University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ph.D.
Study Record Dates
First Submitted
June 23, 2022
First Posted
June 29, 2022
Study Start
July 25, 2022
Primary Completion
August 25, 2023
Study Completion
January 15, 2024
Last Updated
March 6, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share